On May 12, 2022, EnsoData, Inc. closed the transaction. On the same date the company received $10,000,000 in its second tranche closing, bringing the total gross proceeds raised in the transaction to $20,000,000. The tranche was led by new investor, Inspire Medical Systems, Inc. with participation from existing investors including Zetta Venture Partners, Venture Investors, LLC, Supermoon Capital, Colle Capital Partners LP, HealthX Ventures, M25 Group, Board members Justin Mortara, ??Fred Robertson, MD, and other investors. The company received $19,999,975 pursuant to exemption provided under Regulation D from 11 investors.